Amgen Signs a Partnership with Adaptive Biotechnologies to Develop for COVID-19 Published: Apr 09, 2020 | Tags: Amgen, Adaptive Biotechnologies, Develop, Abs, COVID-19 2. Samsung Biologics Signs an Agreement with Vir Biotechnology to Develop Abs for COVID-19 Published: Apr 09, 2020 | Tags: Samsung Biologics, Agreement, Vir Biotechnology, Abs, COVID-19 3. Abbott’s TriClip Transcatheter Tricuspid […]Read More
Tags : Fate Therapeutics
Shots: Fate to receive $50M up front and $50M equity investment at $31/ share and funding for the research and development of collaboration candidates through IND filing. The company will receive up to $1.8B as development & regulatory milestones and up to $1.2B as a commercial milestone along with royalties on global sales of products […]Read More
Latest Posts
